Pharmaron

Pharmaron is a premier, full-service CRO/CDMO supporting the global biopharmaceutical industry. It offers an integrated suite of capabilities spanning laboratory chemistry, analytical sciences, preclinical safety assessment, clinical development, and commercial-scale manufacturing. With a significant operational footprint concentrated in China and expanding facilities in the US and UK, Pharmaron positions itself as a strategic partner to accelerate the development of novel therapeutics across multiple modalities. The company's business model is entirely service-based, generating revenue from its extensive client partnerships.

Integrated CRO/CDMO platform encompassing enabling chemistry technologies (catalysis, engineered enzymes), high-throughput analytical and purification sciences, radiolabelling, and specialized development/manufacturing capabilities for biologics, cell & gene therapies, ADCs, and protein degraders.

Operates in a highly competitive global CRO/CDMO market against large public players like LabCorp, IQVIA, Charles River, Lonza, and WuXi AppTec. Differentiates through its fully integrated 'discovery-to-commercialization' offering, significant scale and cost structure in China, and targeted investments in high-growth modalities like CGT and biologics manufacturing.